Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

Overview of attention for article published in BMC Medicine, October 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 13,616 followers.

#Metabonomics uncovers a reversible proatherogenic #lipid profile during #infliximab therapy of #IBD #UEGWeek https://t.co/nbq1EvOSTh

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of IBD. https://t.co/D3bZu2cFxh

RT @BMCMedicine: #Metabonomics uncovers proatherogenic #lipid profile during #infliximab therapy of inflammatory #bowel disease https://t.c…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.